As­traZeneca chops 210 work­ers, clos­es sites as it looks to con­cen­trate bi­o­log­ics man­u­fac­tur­ing in one place

As­traZeneca is clos­ing down two man­u­fac­tur­ing sites in Col­orado that col­lec­tive­ly em­ployed 210 work­ers, in an ap­par­ent ef­fort to con­sol­i­date its bi­o­log­ics sup­ply chain. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.